NorthRock Partners’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
Other funds holding DXCM
NorthRock Partners's DXCM Position: Q4 2025 in Review
NorthRock Partners sold out of DexCom (DXCM) in Q4 2025, closing a stake of 4,080 shares — an estimated $275K sold.
NorthRock Partners first reported a position in DXCM in Q3 2020 and held it in 19 quarters. The position peaked at $662K in Q1 2024. 922 funds tracked by Wall St. Rank hold DXCM as of Q4 2025.
- NorthRock Partners reported no remaining DexCom position as of Q4 2025 after selling out during the quarter.
- NorthRock Partners sold 4,080 DexCom shares in Q4 2025, an estimated $275K.
- NorthRock Partners first reported a position in DexCom in Q3 2020 and held it in 19 quarters.
- NorthRock Partners's DexCom position peaked at $662K in Q1 2024.
- 922 funds tracked by Wall St. Rank held DexCom as of Q4 2025.
Based on NorthRock Partners's 13F filing for Q4 2025, filed 17 Feb 2026.